Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1986 Aug;83(16):6203–6207. doi: 10.1073/pnas.83.16.6203

Dopaminergic control of 125I-labeled neurotensin binding site density in corticolimbic structures of the rat brain.

D Herve, J P Tassin, J M Studler, C Dana, P Kitabgi, J P Vincent, J Glowinski, W Rostene
PMCID: PMC386468  PMID: 3016745

Abstract

In the rat brain, destruction of dopaminergic cell groups by injections of 6-hydroxydopamine into the ventral mesencephalic tegmentum results in large decreases in the number of neurotensin binding sites in the mesencephalon and the striatum. In contrast, these lesions produce an increase in the number of 125I-labeled neurotensin binding sites in the lateral part of the prefrontal cortex despite a large decrease in cortical dopamine levels. Increases in the number of 125I-labeled neurotensin binding sites in this cortical area as well as in the entorhinal cortex, the nucleus accumbens, and the central part of the striatum were also obtained after chronic blockade of dopamine neurotransmission by a long-acting neuroleptic pipotiazine palmitic ester. We propose that dopamine inputs regulate the density of postsynaptic neurotensin binding sites through cortical and subcortical dopamine receptors. Therefore, some of the clinical effects of neuroleptics in schizophrenic patients could be partly related to changes in neurotensin neurotransmission.

Full text

PDF
6203

Images in this article

6205Image
on p.6205
6205Image
on p.6205
6205Image
on p.6205
6205Image
on p.6205
6205Image
on p.6205

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berger B., Thierry A. M., Tassin J. P., Moyne M. A. Dopaminergic innervation of the rat prefrontal cortex: a fluorescence histochemical study. Brain Res. 1976 Apr 16;106(1):133–145. doi: 10.1016/0006-8993(76)90078-0. [DOI] [PubMed] [Google Scholar]
  2. Brunello N., Barbaccia M. L., Chuang D. M., Costa E. Down-regulation of beta-adrenergic receptors following repeated injections of desmethylimipramine: permissive role of serotonergic axons. Neuropharmacology. 1982 Nov;21(11):1145–1149. doi: 10.1016/0028-3908(82)90172-1. [DOI] [PubMed] [Google Scholar]
  3. Carraway R., Leeman S. E. The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami. J Biol Chem. 1973 Oct 10;248(19):6854–6861. [PubMed] [Google Scholar]
  4. Cooper P. E., Fernstrom M. H., Rorstad O. P., Leeman S. E., Martin J. B. The regional distribution of somatostatin, substance P and neurotensin in human brain. Brain Res. 1981 Aug 10;218(1-2):219–232. doi: 10.1016/0006-8993(81)91302-0. [DOI] [PubMed] [Google Scholar]
  5. Emson P. C., Goedert M., Horsfield P., Rioux F., St Pierre S. The regional distribution and chromatographic characterisation of neurotensin-like immunoreactivity in the rat central nervous system. J Neurochem. 1982 Apr;38(4):992–999. doi: 10.1111/j.1471-4159.1982.tb05340.x. [DOI] [PubMed] [Google Scholar]
  6. Gauchy C., Tassin J. P., Glowinski J., Cheramy A. Isolation and radioenzymic estimation of picogram quantities of dopamine and norepinephrine in biological samples. J Neurochem. 1976 Mar;26(3):471–480. doi: 10.1111/j.1471-4159.1976.tb01498.x. [DOI] [PubMed] [Google Scholar]
  7. Govoni S., Hong J. S., Yang H. Y., Costa E. Increase of neurotensin content elicited by neuroleptics in nucleus accumbens. J Pharmacol Exp Ther. 1980 Nov;215(2):413–417. [PubMed] [Google Scholar]
  8. Haubrich D. R., Martin G. E., Pflueger A. B., Williams M. Neurotensin effects on brain dopaminergic systems. Brain Res. 1982 Jan 7;231(1):216–221. doi: 10.1016/0006-8993(82)90022-1. [DOI] [PubMed] [Google Scholar]
  9. Hökfelt T., Everitt B. J., Theodorsson-Norheim E., Goldstein M. Occurrence of neurotensinlike immunoreactivity in subpopulations of hypothalamic, mesencephalic, and medullary catecholamine neurons. J Comp Neurol. 1984 Feb 1;222(4):543–559. doi: 10.1002/cne.902220407. [DOI] [PubMed] [Google Scholar]
  10. Jennes L., Stumpf W. E., Kalivas P. W. Neurotensin: topographical distribution in rat brain by immunohistochemistry. J Comp Neurol. 1982 Sep 20;210(3):211–224. doi: 10.1002/cne.902100302. [DOI] [PubMed] [Google Scholar]
  11. Kalivas P. W., Burgess S. K., Nemeroff C. B., Prange A. J., Jr Behavioral and neurochemical effects of neurotensin microinjection into the ventral tegmental area of the rat. Neuroscience. 1983 Mar;8(3):495–505. doi: 10.1016/0306-4522(83)90195-1. [DOI] [PubMed] [Google Scholar]
  12. Kalivas P. W., Miller J. S. Neurotensin neurons in the ventral tegmental area project to the medial nucleus accumbens. Brain Res. 1984 May 21;300(1):157–160. doi: 10.1016/0006-8993(84)91351-9. [DOI] [PubMed] [Google Scholar]
  13. Kalivas P. W., Nemeroff C. B., Prange A. J., Jr Increase in spontaneous motor activity following infusion of neurotensin into the ventral tegmental area. Brain Res. 1981 Dec 21;229(2):525–529. doi: 10.1016/0006-8993(81)91016-7. [DOI] [PubMed] [Google Scholar]
  14. Kalivas P. W., Nemeroff C. B., Prange A. J., Jr Neuroanatomical sites of action of neurotensin. Ann N Y Acad Sci. 1982;400:307–318. doi: 10.1111/j.1749-6632.1982.tb31577.x. [DOI] [PubMed] [Google Scholar]
  15. LeMoal M., Stinus L., Galey D. Radiofrequency lesion of the ventral mesencephalic tegmentum: neurological and behavioral considerations. Exp Neurol. 1976 Mar;50(3):521–535. doi: 10.1016/0014-4886(76)90024-8. [DOI] [PubMed] [Google Scholar]
  16. Lindvall O., Björklund A., Divac I. Organization of catecholamine neurons projecting to the frontal cortex in the rat. Brain Res. 1978 Feb 17;142(1):1–24. doi: 10.1016/0006-8993(78)90173-7. [DOI] [PubMed] [Google Scholar]
  17. Manaker S., Winokur A., Rostene W. H., Rainbow T. C. Autoradiographic localization of thyrotropin-releasing hormone receptors in the rat central nervous system. J Neurosci. 1985 Jan;5(1):167–174. doi: 10.1523/JNEUROSCI.05-01-00167.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Manberg P. J., Youngblood W. W., Nemeroff C. B., Rossor M. N., Iversen L. L., Prange A. J., Jr, Kizer J. S. Regional distribution of neurotensin in human brain. J Neurochem. 1982 Jun;38(6):1777–1780. doi: 10.1111/j.1471-4159.1982.tb06664.x. [DOI] [PubMed] [Google Scholar]
  19. Nemeroff C. B., Luttinger D., Hernandez D. E., Mailman R. B., Mason G. A., Davis S. D., Widerlöv E., Frye G. D., Kilts C. A., Beaumont K. Interactions of neurotensin with brain dopamine systems: biochemical and behavioral studies. J Pharmacol Exp Ther. 1983 May;225(2):337–345. [PubMed] [Google Scholar]
  20. Nemeroff C. B., Youngblood W. W., Manberg P. J., Prange A. J., Jr, Kizer J. S. Regional brain concentrations of neuropeptides in Huntington's chorea and schizophrenia. Science. 1983 Sep 2;221(4614):972–975. doi: 10.1126/science.6136092. [DOI] [PubMed] [Google Scholar]
  21. Okuma Y., Fukuda Y., Osumi Y. Neurotensin potentiates the potassium-induced release of endogenous dopamine from rat striatal slices. Eur J Pharmacol. 1983 Sep 16;93(1-2):27–33. doi: 10.1016/0014-2999(83)90027-4. [DOI] [PubMed] [Google Scholar]
  22. Palacios J. M., Kuhar M. J. Neurotensin receptors are located on dopamine-containing neurones in rat midbrain. Nature. 1981 Dec 10;294(5841):587–589. doi: 10.1038/294587a0. [DOI] [PubMed] [Google Scholar]
  23. Quirion R., Chiueh C. C., Everist H. D., Pert A. Comparative localization of neurotensin receptors on nigrostriatal and mesolimbic dopaminergic terminals. Brain Res. 1985 Feb 18;327(1-2):385–389. doi: 10.1016/0006-8993(85)91542-2. [DOI] [PubMed] [Google Scholar]
  24. Reches A., Burke R. E., Jiang D., Wagner H. R., Fahn S. Neurotensin interacts with dopaminergic neurons in rat brain. Peptides. 1983 Jan-Feb;4(1):43–48. doi: 10.1016/0196-9781(83)90163-8. [DOI] [PubMed] [Google Scholar]
  25. Reibaud M., Blanc G., Studler J. M., Glowinski J., Tassin J. P. Non-DA prefronto-cortical efferents modulate D1 receptors in the nucleus accumbens. Brain Res. 1984 Jul 2;305(1):43–50. doi: 10.1016/0006-8993(84)91117-x. [DOI] [PubMed] [Google Scholar]
  26. Rostene W. H., Fischette C. T., McEwen B. S. Modulation by vasoactive intestinal peptide (VIP) of serotonin receptors in membranes from rat hippocampus. J Neurosci. 1983 Dec;3(12):2414–2419. doi: 10.1523/JNEUROSCI.03-12-02414.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Rostène W. H., Fischette C. T., Dussaillant M., McEwen B. S. Adrenal steroid modulation of vasoactive intestinal peptide effect on serotonin1 binding sites in the rat brain shown by in vitro quantitative autoradiography. Neuroendocrinology. 1985 Feb;40(2):129–134. doi: 10.1159/000124133. [DOI] [PubMed] [Google Scholar]
  28. Rostène W., Mourre C. Préparation de standards iodés pour radioautographie quantitative in vitro à l'aide d'un film sensible au tritium. C R Acad Sci III. 1985;301(5):245–250. [PubMed] [Google Scholar]
  29. Sadoul J. L., Chécler F., Kitabgi P., Rostène W., Javoy-Agid F., Vincent J. P. Loss of high affinity neurotensin receptors in substantia nigra from parkinsonian subjects. Biochem Biophys Res Commun. 1984 Nov 30;125(1):395–404. doi: 10.1016/s0006-291x(84)80381-2. [DOI] [PubMed] [Google Scholar]
  30. Sadoul J. L., Kitabgi P., Rostène W., Javoy-Agid F., Agid Y., Vincent J. P. Characterization and visualization of neurotensin binding to receptor sites in human brain. Biochem Biophys Res Commun. 1984 Apr 16;120(1):206–213. doi: 10.1016/0006-291x(84)91434-7. [DOI] [PubMed] [Google Scholar]
  31. Sadoul J. L., Mazella J., Amar S., Kitabgi P., Vincent J. P. Preparation of neurotensin selectively iodinated on the tyrosine 3 residue. Biological activity and binding properties on mammalian neurotensin receptors. Biochem Biophys Res Commun. 1984 May 16;120(3):812–819. doi: 10.1016/s0006-291x(84)80179-5. [DOI] [PubMed] [Google Scholar]
  32. Scatton B., Boireau A., Garret C., Glowinski J., Julou L. Action of the palmitic ester of pipotiazine on dopamine metabolism in the nigro-striatal, meso-limbic and meso-cortiacal systems. Naunyn Schmiedebergs Arch Pharmacol. 1977 Jan;296(2):169–175. doi: 10.1007/BF00508470. [DOI] [PubMed] [Google Scholar]
  33. Scott J. A., Crews F. T. Increase in serotonin2 receptor density in rat cerebral cortex slices by stimulation of beta-adrenergic receptors. Biochem Pharmacol. 1985 May 1;34(9):1585–1588. doi: 10.1016/0006-2952(85)90705-1. [DOI] [PubMed] [Google Scholar]
  34. Tassin J. P., Simon H., Hervé D., Blanc G., Le Moal M., Glowinski J., Bockaert J. Non-dopaminergic fibres may regulate dopamine-sensitive adenylate cyclase in the prefrontal cortex and nucleus accumbens. Nature. 1982 Feb 25;295(5851):696–698. doi: 10.1038/295696a0. [DOI] [PubMed] [Google Scholar]
  35. Tassin J. P., Studler J. M., Hervé D., Blanc G., Glowinski J. Contribution of noradrenergic neurons to the regulation of dopaminergic (D1) receptor denervation supersensitivity in rat prefrontal cortex. J Neurochem. 1986 Jan;46(1):243–248. doi: 10.1111/j.1471-4159.1986.tb12953.x. [DOI] [PubMed] [Google Scholar]
  36. Uhl G. R. Distribution of neurotensin and its receptor in the central nervous system. Ann N Y Acad Sci. 1982;400:132–149. doi: 10.1111/j.1749-6632.1982.tb31565.x. [DOI] [PubMed] [Google Scholar]
  37. Uhl G. R., Kuhar M. J. Chronic neuroleptic treatment enhances neurotensin receptor binding in human and rat substantia nigra. Nature. 1984 May 24;309(5966):350–352. doi: 10.1038/309350a0. [DOI] [PubMed] [Google Scholar]
  38. Uhl G. R., Whitehouse P. J., Price D. L., Tourtelotte W. W., Kuhar M. J. Parkinson's disease: depletion of substantia nigra neurotensin receptors. Brain Res. 1984 Aug 6;308(1):186–190. doi: 10.1016/0006-8993(84)90935-1. [DOI] [PubMed] [Google Scholar]
  39. Widerlöv E., Lindström L. H., Besev G., Manberg P. J., Nemeroff C. B., Breese G. R., Kizer J. S., Prange A. J., Jr Subnormal CSF levels of neurotensin in a subgroup of schizophrenic patients: normalization after neuroleptic treatment. Am J Psychiatry. 1982 Sep;139(9):1122–1126. doi: 10.1176/ajp.139.9.1122. [DOI] [PubMed] [Google Scholar]
  40. Young W. S., 3rd, Kuhar M. J. Neurotensin receptor localization by light microscopic autoradiography in rat brain. Brain Res. 1981 Feb 16;206(2):273–285. doi: 10.1016/0006-8993(81)90532-1. [DOI] [PubMed] [Google Scholar]
  41. Young W. S., 3rd, Kuhar M. J. Neurotensin receptors: autoradiographic localization in rat CNS. Eur J Pharmacol. 1979 Oct 26;59(1-2):161–163. doi: 10.1016/0014-2999(79)90042-6. [DOI] [PubMed] [Google Scholar]
  42. de Quidt M. E., Emson P. C. Neurotensin facilitates dopamine release in vitro from rat striatal slices. Brain Res. 1983 Sep 12;274(2):376–380. doi: 10.1016/0006-8993(83)90722-9. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES